The COLchicine and Atrial FIBrillation Trial
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.
Also called NCT05928728
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT05928728
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT05928728. Randomized; quadruple masking; primary purpose treatment. Start 2023-07-03 (actual); primary completion 2026-06-14 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The COLchicine and Atrial FIBrillation Trial
- Acronym
- COLFIB
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Colchicine
- Intervention (Drug)
- Placebo
- Lead sponsor
- Herlev and Gentofte Hospital
Record details
- Record id
cardio:ct-nct05928728- Content hash
c247e018e18af78e6c3f5463b197c589ea02da92d8d5ffd24eb0b2735f13035c